Par Drugs and Chemicals Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 239.99 million compared to INR 229.33 million a year ago. Revenue was INR 242.28 million compared to INR 229.7 million a year ago. Net income was INR 34.22 million compared to INR 18.68 million a year ago. Basic earnings per share was INR 2.78 compared to INR 1.52 a year ago. Diluted earnings per share was INR 2.78 compared to INR 1.52 a year ago.
For the nine months, sales was INR 728.21 million compared to INR 712.57 million a year ago. Revenue was INR 731.11 million compared to INR 714.64 million a year ago. Net income was INR 107.82 million compared to INR 78.87 million a year ago. Basic earnings per share was INR 8.76 compared to INR 6.41 a year ago. Diluted earnings per share was INR 8.76 compared to INR 6.41 a year ago.